Addressing the aberrant interactions between immune cells and biomaterials represents an unmet need in biomaterial research. Although progress has been made in the development of bioinert coatings, identifying and targeting relevant cellular and molecular pathways can provide additional therapeutic strategies to address this major healthcare concern. To that end, we describe the immune inhibitory motif, receptor–ligand pairing of signal regulatory protein alpha and its cognate ligand CD47 as a potential signaling pathway to enhance biocompatibility. The goals of this article are to detail the known roles of CD47–signal regulatory protein alpha signal transduction pathway and to describe how immobilized CD47 can be used to mitigate the immune response to biomaterials. Current applications of CD47-modified biomaterials will also be discussed herein.
AndersonJMMcNallyAK. Biocompatibility of implants: lymphocyte/macrophage interactions. Semin Immunopathol2011; 33: 221–33.
2.
StevensKNAldenhoffYBvan der VeenFHMaessenJGKooleLH. Bioengineering of improved biomaterials coatings for extracorporeal circulation requires extended observation of blood-biomaterial interaction under flow. J Biomed Biotechnol2007; 2007: 29464–29464.
3.
EdmundsLHJr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg1998; 66(5 Suppl): S12–16.
4.
HillGE. The inflammatory response to cardiopulmonary bypass. Int Anesthesiol Clin1996; 34: 95–108.
5.
HogueCWJrPalinCAArrowsmithJE. Cardiopulmonary bypass management and neurologic outcomes: an evidence-based appraisal of current practices. Anesth Analg2006; 103: 21–37.
6.
ToutouzasKKaranasosAStefanadisC. Inflammatory mechanisms of adverse reactions to BMS. Curr Vasc Pharmacol2013; 11: 379–91.
7.
YooJWChambersEMitragotriS. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr Pharm Des2010; 16: 2298–7.
8.
BellingerDCBernsteinJHKirkwoodMWRappaportLANewburgerJW. Visual-spatial skills in children after open-heart surgery. J Dev Behav Pediatr2003; 24: 169–79.
GaynorJW. Periventricular leukomalacia following neonatal and infant cardiac surgery. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu2004; 7: 133–40.
11.
LandisC. Why the inflammatory response is important to the cardiac surgical patient. J Extra Corpor Technol2007; 39: 281–84.
12.
LevyJHAdkinsonNFJr. Anaphylaxis during cardiac surgery: implications for clinicians. Anesth Analg2008; 106: 392–403.
13.
LevyJHTanakaKA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg2003; 75: S715–20.
14.
McGuinnessJBouchier-HayesDRedmondJM. Understanding the inflammatory response to cardiac surgery. Surgeon2008; 6: 162–71.
15.
JenneyCRAndersonJM. Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J Biomed Mater Res2000; 49: 435–47.
16.
NilssonBEkdahlKNMollnesTELambrisJD. The role of complement in biomaterial-induced inflammation. Mol Immunol2007; 44: 82–94.
17.
SleeJBChristianAJLevyRJStachelekSJ. Addressing the inflammatory response to clinically relevant polymers by manipulating the host response using ITIM domain-containing receptors. Polymers2014; 6: 2526–51.
18.
SperlingCMaitzMFTalkenbergerSGouzyMFGrothTWernerC. In vitro blood reactivity to hydroxylated and non-hydroxylated polymer surfaces. Biomaterials2007; 28: 3617–25.
19.
NygrenHErikssonCLausmaaJ. Adhesion and activation of platelets and polymorphonuclear granulocyte cells at TiO2 surfaces. J Lab Clin Med1997; 129: 35–46.
20.
AndersonJMRodriguezAChangDT. Foreign body reaction to biomaterials. Semin Immunol2008; 20: 86–100.
21.
DadsetanMChristensonEMUngerFAusbornMKisselTHiltnerAAndersonJM. In vivo biocompatibility and biodegradation of poly(ethylene carbonate). J Control Release2003; 93: 259–70.
22.
JenneyCRAndersonJM. Effects of surface-coupled polyethylene oxide on human macrophage adhesion and foreign body giant cell formation in vitro. J Biomed Mater Res1999; 44: 206–16.
23.
BajajGVan AlstineWGYeoY. Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release. PLoS One2012; 7: e30899–e30899.
24.
GodaTToyaMMatsumotoAMiyaharaY. Poly(3,4-ethylenedioxythiophene) bearing phosphorylcholine groups for metal-free, antibody-free, and low-impedance biosensors specific for C-reactive protein. ACS Appl Mater Interf2015; 7: 27440–48.
25.
ZhangLCaoZBaiTCarrLElla-MenyeJRIrvinCRatnerBDJiangS. Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nature Biotechnol2013; 31: 553–56.
26.
AlmeidaCRSerraTOliveiraMIPlanellJABarbosaMANavarroM. Impact of 3-D printed PLA- and chitosan-based scaffolds on human monocyte/macrophage responses: unraveling the effect of 3-D structures on inflammation. Acta Biomater2014; 10: 613–22.
27.
KyleDJOikonomouAHillEBayatA. Development and functional evaluation of biomimetic silicone surfaces with hierarchical micro/nano-topographical features demonstrates favourable in vitro foreign body response of breast-derived fibroblasts. Biomaterials2015; 52: 88–102.
28.
LiJChuMKGordijoCRAbbasiAZChenKAdissuHALohnMGiaccaAPlettenburgOWuXY. Microfabricated microporous membranes reduce the host immune response and prolong the functional lifetime of a closed-loop insulin delivery implant in a type 1 diabetic rat model. Biomaterials2015; 47: 51–61.
29.
BartoszewiczZPJaffeHSasakiMMollerJRStebbinsJWGebrekristosHQuarlesRH. Prominent 85-kDa oligomannosidic glycoproteins of rat brain are signal regulatory proteins and include the SHP substrate-1 for tyrosine phosphatases. J Neurochem1999; 72: 1688–93.
30.
BrookeGPParsonsKRHowardCJ. Cloning of two members of the SIRP alpha family of protein tyrosine phosphatase binding proteins in cattle that are expressed on monocytes and a subpopulation of dendritic cells and which mediate binding to CD4 T cells. Eur J Immunol1998; 28: 1–11.
31.
JakelAClarkHReidKBSimRB. The human lung surfactant proteins A (SP-A) and D (SP-D) interact with apoptotic target cells by different binding mechanisms. Immunobiology2010; 215: 551–58.
32.
PalaniyarNClarkHNadesalingamJHawgoodSReidKB. Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance, in vivo. Ann N Y Acad Sci2003; 1010: 471–75.
33.
SchagatTLWoffordJAWrightJR. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J Immunol2001; 166: 2727–33.
34.
VandivierRWOgdenCAFadokVAHoffmannPRBrownKKBottoMWalportMJFisherJHHensonPMGreeneKE. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol2002; 169: 3978–86.
35.
JanssenWJMcPhillipsKADickinsonMGLindermanDJMorimotoKXiaoYQOldhamKMVandivierRWHensonPMGardaiSJ. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP alpha. Am J Respir Crit Care Med2008; 178: 158–67.
36.
UedaMAlferievISSimonsSBHebbelRPLevyRJStachelekSJ. CD47-dependent molecular mechanisms of blood outgrowth endothelial cell attachment on cholesterol-modified polyurethane. Biomaterials2010; 31: 6394–99.
37.
ShinoharaMOhyamaNMurataYOkazawaHOhnishiHIshikawaOMatozakiT. CD47 regulation of epithelial cell spreading and migration, and its signal transduction. Cancer Sci2006; 97: 889–95.
38.
ShahanTAZiaieZPascoSFawziABellonGMonboisseJCKefalidesNA. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res1999; 59: 4584–90.
SmadjaDMd'AudigierCBiecheIEvrardSMaugeLDiasJVLabreucheJLaurendeauIMarsacBDizierBWagner-BallonOBoisson-VidalCMorandiVDuong-Van-HuyenJPBrunevalPDignat-GeorgeFEmmerichJGaussemP. Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol2011; 31: 551–9.
41.
NarizhnevaNVRazorenovaOVPodrezEAChenJChandrasekharanUMDiCorletoPEPlowEFTopolEJByzovaTV. Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J2005; 19: 1158–60.
42.
IsenbergJSJiaYFukuyamaJSwitzerCHWinkDARobertsDD. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake. J Biol Chem2007; 282: 15404–15.
43.
JiangPLagenaurCFNarayananV. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem1999; 274: 559–62.
44.
TsaiRKDischerDE. Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol2008; 180: 989–1003.
45.
van den BergTKvan der SchootCE. Innate immune ‘self' recognition: a role for CD47-SIRPalpha interactions in hematopoietic stem cell transplantation. Trends Immunol2008; 29: 203–6.
46.
TsaiRKRodriguezPLDischerDE. Self inhibition of phagocytosis: the affinity of ‘marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels. Blood Cells Mol Dis2010; 45: 67–74.
47.
SubramanianSTsaiRDischerDE. The ‘metabolon,' CD47, and the ‘phagocytic synapse': molecular co-localization and species divergence. Transfus Clin Biol2006; 13: 31–8.
48.
SubramanianSParthasarathyRSenSBoderETDischerDE. Species- and cell type-specific interactions between CD47 and human SIRPalpha. Blood2006; 107: 2548–56.
49.
OldenborgPAZheleznyakAFangYFLagenaurCFGreshamHDLindbergFP. Role of CD47 as a marker of self on red blood cells. Science2000; 288: 2051–54.
50.
TakenakaKPrasolavaTKWangJCMortin-TothSMKhaloueiSGanOIDickJEDanskaJS. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol2007; 8: 1313–23.
51.
JaiswalSJamiesonCHPangWWParkCYChaoMPMajetiRTraverDvan RooijenNWeissmanIL. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell2009; 138: 271–85.
52.
CampbellIGFreemontPSFoulkesWTrowsdaleJ. An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains. Cancer Res1992; 52: 5416–20.
53.
InabaKMetlayJPCrowleyMTWitmer-PackMSteinmanRM. Dendritic cells as antigen presenting cells in vivo. Int Rev Immunol1990; 6: 197–206.
54.
KraalG. Cells in the marginal zone of the spleen. International review of cytology1992; 132: 31–74.
55.
SteinmanRMPackMInabaK. Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev1997; 156: 25–37.
56.
SaitoYIwamuraHKanekoTOhnishiHMurataYOkazawaHKanazawaYSato-HashimotoMKobayashiHOldenborgPANaitoMKanekoYNojimaYMatozakiT. Regulation by SIRPalpha of dendritic cell homeostasis in lymphoid tissues. Blood2010; 116: 3517–25.
57.
HagnerudSMannaPPCellaMStenbergAFrazierWAColonnaMOldenborgPA. Deficit of CD47 results in a defect of marginal zone dendritic cells, blunted immune response to particulate antigen and impairment of skin dendritic cell migration. J Immunol2006; 176: 5772–78.
58.
MuellerSNGermainRN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol2009; 9: 618–29.
59.
LutherSABidgolAHargreavesDCSchmidtAXuYPaniyadiJMatloubianMCysterJG. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol2002; 169: 424–33.
60.
Sato-HashimotoMSaitoYOhnishiHIwamuraHKanazawaYKanekoTKusakariSKotaniTMoriMMurataYOkazawaHWareCFOldenborgPANojimaYMatozakiT. Signal regulatory protein alpha regulates the homeostasis of T lymphocytes in the spleen. J Immunol2011; 187: 291–97.
61.
WisniewskiNKlitzmanBMillerBReichertWM. Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J Biomed Mater Res2001; 57: 513–21.
62.
WisniewskiNRajamandNAdamssonULinsPEReichertWMKlitzmanBUngerstedtU. Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. Am J Physiol Endocrinol Metab2002; 282: E1316–23.
63.
FinleyMJRauovaLAlferievISWeiselJWLevyRJStachelekSJ. Diminished adhesion and activation of platelets and neutrophils with CD47 functionalized blood contacting surfaces. Biomaterials2012; 33: 5803–11.
64.
IsenbergJSRobertsDDFrazierWA. CD47: a new target in cardiovascular therapy. Arterioscler Thromb Vasc Biol2008; 28: 615–21.
65.
SaumetAde JesusNLegrandCDubernardV. Association of thrombospondin-1 with the actin cytoskeleton of human thrombin-activated platelets through an alphaIIbbeta3- or CD36-independent mechanism. Biochem J2002; 363: 473–82.
StachelekSJFinleyMJAlferievISWangFTsaiRKEckellsECTomczykNConnollyJMDischerDEEckmannDMLevyRJ. The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation. Biomaterials2011; 32: 4317–26.
OkerekeCSBaratSAAbdel-RahmanMS. Safety evaluation of benzophenone-3 after dermal administration in rats. Toxicol Lett1995; 80: 61–7.
70.
RobisonSHOdioMRThompsonEDAardemaMJKrausAL. Assessment of the in vivo genotoxicity of 2-hydroxy 4-methoxybenzophenone. Environ Mol Mutagen1994; 23: 312–17.
71.
RodriguezPLHaradaTChristianDAPantanoDATsaiRKDischerDE. Minimal “Self” peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science2013; 339: 971–75.
72.
ChaoMPAlizadehAATangCJanMWeissman-TsukamotoRZhaoFParkCYWeissmanILMajetiR. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res2011; 71: 1374–84.
73.
EdrisBWeiskopfKVolkmerAKVolkmerJPWillinghamSBContreras-TrujilloHLiuJMajetiRWestRBFletcherJABeckAHWeissmanILvan de RijnM. Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma. Proc Natl Acad Sci USA2012; 109: 6656–61.
74.
KimDWangJWillinghamSBMartinRWernigGWeissmanIL. Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia2012; 26: 2538–45.
75.
McCrackenMNChaACWeissmanIL. Molecular pathways: activating T cells after cancer cell phagocytosis from blockade of CD47 “Don't Eat Me” signals. Clin Cancer Res2015; 21: 3597–01.
76.
BrunsHBessellCVarelaJCHauptCFangJPasemannSMackensenAOelkeMSchneckJPSchutzC. CD47 enhances in vivo functionality of artificial antigen-presenting cells. Clin Cancer Res2015; 21: 2075–83.
77.
HuCMFangRHLukBTChenKNCarpenterCGaoWZhangKZhangL. Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale2013; 5: 2664–68.
78.
HuCMFangRHLukBTZhangL. Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. Nanoscale2014; 6: 65–75.
79.
HuCMZhangLAryalSCheungCFangRHZhangL. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA2011; 108: 10980–85.
80.
GaoWHuCMFangRHLukBTSuJZhangL. Surface functionalization of gold nanoparticles with red blood cell membranes. Adv Mater2013; 25: 3549–53.
StokesKUrbanskiPUptonJ. The in vivo auto-oxidation of polyether polyurethane by metal ions. J Biomater Sci Polym Ed1990; 1: 207–30.
83.
ChristensonEMAndersonJMHiltnerA. Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo and in vitro correlations. J Biomed Mater Res A2004; 70: 245–55.
84.
ChristensonEMAndersonJMHiltnerA. Antioxidant inhibition of poly(carbonate urethane) in vivo biodegradation. J Biomed Mater Res A2006; 76: 480–90.
85.
SchubertMAWigginsMJSchaeferMPHiltnerAAndersonJM. Oxidative biodegradation mechanisms of biaxially strained poly(etherurethane urea) elastomers. J Biomed Mater Res1995; 29: 337–47.
86.
StachelekSJAlferievIFulmerJIschiropoulosHLevyRJ. Biological stability of polyurethane modified with covalent attachment of di-tert-butyl-phenol. J Biomed Mater Res A2007; 82: 1004–11.
87.
WigginsMJWilkoffBAndersonJMHiltnerA. Biodegradation of polyether polyurethane inner insulation in bipolar pacemaker leads. J Biomed Mater Res2001; 58: 302–7.
88.
StachelekSJAlferievIUedaMEckelsECGleasonKTLevyRJ. Prevention of polyurethane oxidative degradation with phenolic antioxidants covalently attached to the hard segments: structure-function relationships. J Biomed Mater Res A2010; 94: 751–59.
89.
BruckSD. Medical applications of polymeric materials. Med Prog Technol1982; 9: 1–16.
90.
MaitzMFSperlingCWernerC. Immobilization of the irreversible thrombin inhibitor D-Phe-Pro-Arg-chloromethylketone: a concept for hemocompatible surfaces?J Biomed Mater Res A2010; 94: 905–12.
91.
SperlingCSalchertKStrellerUWernerC. Covalently immobilized thrombomodulin inhibits coagulation and complement activation of artificial surfaces in vitro. Biomaterials2004; 25: 5101–13.
92.
WeberNWendelHPZiemerG. Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption. Biomaterials2002; 23: 429–39.
